Delivery Order SPE2DE24D0013-SPE2D626F07J9

The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $3,638 for COVID-19/Influenza/RSV diagnostic supplies. The delivery order, issued on December 10, 2025, with an ultimate completion date of December 24, 2025, represents a routine procurement action under the DLA Medical Supply Chain's established contracting framework for infectious disease testing solutions. No set-aside designation was applied to this award, reflecting Cepheid's competitive positioning as a primary federal supplier of diagnostic reagents and test kits. The contract will be performed at Cepheid's headquarters location in Sunnyvale, California.

This modest delivery order is consistent with Cepheid's extensive portfolio of federal contracts across multiple agencies, including substantial indefinite delivery contracts with the Department of Veterans Affairs valued at over $39.5 million through 2030. Cepheid's core competency in providing rapid molecular diagnostic testing through its GeneXpert platform has positioned the company as a preferred supplier across the federal healthcare system, supporting agencies including the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company's role extends beyond routine procurement to include research collaboration on drug-resistant tuberculosis detection and international capacity-building initiatives, demonstrating its significance as a critical infrastructure provider for federal diagnostic capabilities.